MedPath

Comprehensive detection of childhood cancer predisposing genes using exome sequencing: The next step towards personalized treatment and cancer prevention.

Conditions
kanker op de kinderleeftijd
childhood cancer
pediatric tumors
10027664
10027655
Registration Number
NL-OMON37736
Lead Sponsor
niversitair Medisch Centrum Sint Radboud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
180
Inclusion Criteria

Individuals diagnosed with any form of childhood cancer and one of the following characteristics will be included:
• Intellectual disability,
• Congenital anomalies,
• Adult type of cancer in a child
• First or second degree relative with the same type of cancer.
• Second primary malignancy
as well as their parents

Exclusion Criteria

A known genetic defect in the family for a cancer unrelated condition, of which the child might be a carrier but about which the child/parents do not want to be informed.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Mutations in known and novel pediatric cancer predisposing genes.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The results of this exome sequencing project will likely result in novel<br /><br>clinical, molecular genetic, and functional studies in order to explore the<br /><br>impact on clinical practice and to investigate novel functional pathways in<br /><br>childhood cancer initiation and development. </p><br>
© Copyright 2025. All Rights Reserved by MedPath